Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ATIS is on the move! -- Ignore unavailable to you. Want to Upgrade?

To: Bruce L who wrote (2161)	8/24/2001 2:12:41 PM
From: Gary Stern	Read Replies (1) \| Respond to of 2205

I don't think the move is as a result of leaked news because the volume is much too light. Clearly, however, approval of DG is imminent, the launch of a TV campaign for the sale of the Nouricel face cream is scheduled for September (original date mid July), and a partner to begin trials on a cardio-patch about to be announced. I think today's rise is a bit of euphoria related to the general upbeat tone in the market. It's my sense that investors are starved for good news and that even "the fall-off in sales appears to be ending" from CSCO was enough to generate positive interest. If DG approval can come along on a positive day all the longs will be pleasantly surprised. I have a pretty good feeling that this one may make it big.